275 related articles for article (PubMed ID: 27224921)
21. Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines.
Yang GJ; Ko CN; Zhong HJ; Leung CH; Ma DL
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30650517
[TBL] [Abstract][Full Text] [Related]
22. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
Hinohara K; Wu HJ; Vigneau S; McDonald TO; Igarashi KJ; Yamamoto KN; Madsen T; Fassl A; Egri SB; Papanastasiou M; Ding L; Peluffo G; Cohen O; Kales SC; Lal-Nag M; Rai G; Maloney DJ; Jadhav A; Simeonov A; Wagle N; Brown M; Meissner A; Sicinski P; Jaffe JD; Jeselsohn R; Gimelbrant AA; Michor F; Polyak K
Cancer Cell; 2018 Dec; 34(6):939-953.e9. PubMed ID: 30472020
[TBL] [Abstract][Full Text] [Related]
23. Tungsten exposure causes a selective loss of histone demethylase protein.
Laulicht-Glick F; Wu F; Zhang X; Jordan A; Brocato J; Kluz T; Sun H; Costa M
Mol Carcinog; 2017 Jul; 56(7):1778-1788. PubMed ID: 28218462
[TBL] [Abstract][Full Text] [Related]
24. The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells.
Kong SY; Kim W; Lee HR; Kim HJ
FASEB J; 2018 Feb; 32(2):1108-1119. PubMed ID: 29212818
[TBL] [Abstract][Full Text] [Related]
25. Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
Tumber A; Nuzzi A; Hookway ES; Hatch SB; Velupillai S; Johansson C; Kawamura A; Savitsky P; Yapp C; Szykowska A; Wu N; Bountra C; Strain-Damerell C; Burgess-Brown NA; Ruda GF; Fedorov O; Munro S; England KS; Nowak RP; Schofield CJ; La Thangue NB; Pawlyn C; Davies F; Morgan G; Athanasou N; Müller S; Oppermann U; Brennan PE
Cell Chem Biol; 2017 Mar; 24(3):371-380. PubMed ID: 28262558
[TBL] [Abstract][Full Text] [Related]
26. Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.
Horton JR; Liu X; Gale M; Wu L; Shanks JR; Zhang X; Webber PJ; Bell JSK; Kales SC; Mott BT; Rai G; Jansen DJ; Henderson MJ; Urban DJ; Hall MD; Simeonov A; Maloney DJ; Johns MA; Fu H; Jadhav A; Vertino PM; Yan Q; Cheng X
Cell Chem Biol; 2016 Jul; 23(7):769-781. PubMed ID: 27427228
[TBL] [Abstract][Full Text] [Related]
27. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism.
Torres IO; Kuchenbecker KM; Nnadi CI; Fletterick RJ; Kelly MJ; Fujimori DG
Nat Commun; 2015 Feb; 6():6204. PubMed ID: 25686748
[TBL] [Abstract][Full Text] [Related]
28. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
[TBL] [Abstract][Full Text] [Related]
29. Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance.
Xu L; Wu H; Hu X
Acta Biochim Pol; 2021 Jul; 68(4):593-602. PubMed ID: 34270886
[TBL] [Abstract][Full Text] [Related]
30. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.
Vinogradova M; Gehling VS; Gustafson A; Arora S; Tindell CA; Wilson C; Williamson KE; Guler GD; Gangurde P; Manieri W; Busby J; Flynn EM; Lan F; Kim HJ; Odate S; Cochran AG; Liu Y; Wongchenko M; Yang Y; Cheung TK; Maile TM; Lau T; Costa M; Hegde GV; Jackson E; Pitti R; Arnott D; Bailey C; Bellon S; Cummings RT; Albrecht BK; Harmange JC; Kiefer JR; Trojer P; Classon M
Nat Chem Biol; 2016 Jul; 12(7):531-8. PubMed ID: 27214401
[TBL] [Abstract][Full Text] [Related]
31. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis.
Yoo J; Kim GW; Jeon YH; Kim JY; Lee SW; Kwon SH
Exp Mol Med; 2022 Dec; 54(12):2107-2117. PubMed ID: 36509829
[TBL] [Abstract][Full Text] [Related]
32. Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
Horton JR; Woodcock CB; Chen Q; Liu X; Zhang X; Shanks J; Rai G; Mott BT; Jansen DJ; Kales SC; Henderson MJ; Cyr M; Pohida K; Hu X; Shah P; Xu X; Jadhav A; Maloney DJ; Hall MD; Simeonov A; Fu H; Vertino PM; Cheng X
J Med Chem; 2018 Dec; 61(23):10588-10601. PubMed ID: 30392349
[TBL] [Abstract][Full Text] [Related]
33. Cadmium induces histone H3 lysine methylation by inhibiting histone demethylase activity.
Xiao C; Liu Y; Xie C; Tu W; Xia Y; Costa M; Zhou X
Toxicol Sci; 2015 May; 145(1):80-9. PubMed ID: 25673502
[TBL] [Abstract][Full Text] [Related]
34. KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance.
Gaillard S; Charasson V; Ribeyre C; Salifou K; Pillaire MJ; Hoffmann JS; Constantinou A; Trouche D; Vandromme M
Biol Open; 2021 May; 10(5):. PubMed ID: 34184733
[TBL] [Abstract][Full Text] [Related]
35. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.
Longbotham JE; Chio CM; Dharmarajan V; Trnka MJ; Torres IO; Goswami D; Ruiz K; Burlingame AL; Griffin PR; Fujimori DG
Nat Commun; 2019 Jan; 10(1):94. PubMed ID: 30626866
[TBL] [Abstract][Full Text] [Related]
36. H3K4me3 Demethylase Kdm5a Is Required for NK Cell Activation by Associating with p50 to Suppress SOCS1.
Zhao D; Zhang Q; Liu Y; Li X; Zhao K; Ding Y; Li Z; Shen Q; Wang C; Li N; Cao X
Cell Rep; 2016 Apr; 15(2):288-99. PubMed ID: 27050510
[TBL] [Abstract][Full Text] [Related]
37. Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3.
Ham J; Lee S; Lee H; Jeong D; Park S; Kim SJ
Am J Chin Med; 2018; 46(6):1333-1355. PubMed ID: 30149757
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase.
Zhou X; Sun H; Chen H; Zavadil J; Kluz T; Arita A; Costa M
Cancer Res; 2010 May; 70(10):4214-21. PubMed ID: 20406991
[TBL] [Abstract][Full Text] [Related]
39. Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin.
Kataria A; Tyagi S
Epigenetics; 2023 Dec; 18(1):2268813. PubMed ID: 37838974
[TBL] [Abstract][Full Text] [Related]
40. Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.
Ohguchi H; Park PMC; Wang T; Gryder BE; Ogiya D; Kurata K; Zhang X; Li D; Pei C; Masuda T; Johansson C; Wimalasena VK; Kim Y; Hino S; Usuki S; Kawano Y; Samur MK; Tai YT; Munshi NC; Matsuoka M; Ohtsuki S; Nakao M; Minami T; Lauberth S; Khan J; Oppermann U; Durbin AD; Anderson KC; Hideshima T; Qi J
Blood Cancer Discov; 2021 Jul; 2(4):370-387. PubMed ID: 34258103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
